油價

Lex_Overheating oil

Investors love bubbles, but they also need something to worry about. The latest is the oil price. Brent crude is nearly a fifth higher per barrel now than at the end of 2011 – at $123, not far off its 2011 peak of $127. Gasoline at the US pump is approaching $4 a gallon. Oil producers may be happy, but everyone from President Barack Obama’s re-election team to mom-and-dad stockpickers are watching nervously. They should worry less.

For a start, there is more than one factor driving up the oil price. The impact of rich-world quantitative easing on dollar-denominated assets such as oil is hotly debated. But what is certain is that there is hardly a squeeze going on at the moment. Oil demand is falling in industrialised countries, as HSBC points out. Even in China, consumption in December was only 1 per cent up year on year, compared with a 10 per cent clip a year ago. That leaves political risk around Iran as the most likely reason for this latest price surge, rather than any nastier structural issue.

But even if the oil price grinds higher, equity investors should not fret. Equities actually do well in times of rising oil prices because higher prices mostly reflect robust global growth. Only if the rise is sparked by a big supply shock – the first oil crisis in 1973, or Iraq’s invasion of Kuwait in 1990 – do stocks go into retreat. A blockade by Iran of the Strait of Hormuz, through which a fifth of global oil supplies travel, would fit the definition of a supply shock and take all bets off the table. But a resolution of the Iran problem would drain oil of its risk premium.

您已閱讀77%(1597字),剩餘23%(474字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。

中東期待沙烏地阿拉伯制衡川普

阿拉伯國家希望穆罕默德王儲和美國當選總統川普的密切關係能夠緩和川普政府的中東政策。

投資者押注防務支出增加,Palantir成爲「川普交易」贏家之一

彼得•蒂爾創立的數據公司的最大客戶是美國政府,自川普本月當選以來,其市值增加了230億美元。

Lex專欄:成長來之不易,雀巢前景平淡

要實現其成長目標,這家瑞士集團需要增加行銷投資。

Lex專欄:便宜商品是沃爾瑪股價上漲的基礎

沃爾瑪通過吸引高收入顧客和增加其他收入來源,出色地應對了經濟不景氣和通膨帶來的挑戰。

Lex專欄:奢侈品品牌寄希望於自己的美國夢

奢侈品在美國越來越具有吸引力,可能爲該行業提供新的成長跑道。

諾和諾德準備下一代減肥藥的試驗結果

這家丹麥公司預計,最新數據將顯示CagriSema可在一年多的時間內減輕25%的體重。
設置字型大小×
最小
較小
默認
較大
最大
分享×